Women and heart disease, the underrecognized burden: Sex differences, biases, and unmet clinical and research challenges

Clinical Science

Volumn 130, Issue 8, 2016, Pages 551-563

  Westerman, Stacy ^a   Wenger, Nanette K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Heart failure; Heart rhythm; Sex differences; Women

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; NITRIC ACID DERIVATIVE;

AORTA STENOSIS; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; HEART DISEASE; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART RHYTHM; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; ISCHEMIC HEART DISEASE; LEFT VENTRICULAR ASSIST DEVICE; MITRAL VALVE PROLAPSE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERIPARTUM CARDIOMYOPATHY; PRACTICE GUIDELINE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEX DIFFERENCE; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; TAKOTSUBO CARDIOMYOPATHY; WOMEN'S HEALTH; CARDIOLOGY; CAUSE OF DEATH; CORONARY ARTERY BLOOD FLOW; FEMALE; HEALTH CARE DISPARITY; HEALTH DISPARITY; HEART DISEASES; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART STROKE VOLUME; MEDICAL RESEARCH; MORTALITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL BIAS; TREATMENT OUTCOME; TRENDS;

BIAS (EPIDEMIOLOGY); BIOMEDICAL RESEARCH; CARDIOLOGY; CAUSE OF DEATH; CORONARY CIRCULATION; FEMALE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HEART DISEASES; HEART RATE; HUMANS; PREGNANCY; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; WOMEN'S HEALTH;

EID: 84973523416     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150586     Document Type: Review

References (129)

1. Gillum, R.F. (1988) The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am. Heart J. 116 (1 Pt 1), 163-174
2. Okin, P.M., Roman, M.J., Devereux, R.B. and Kligfield, P. (1995) Gender differences and the electrocardiogram in left ventricular hypertrophy. Hypertension 25, 242-249
3. Gowd, B.M. and Thompson, P.D. (2012) Effect of female sex on cardiac arrhythmias. Cardiol. Rev. 20, 297-303
4. Wolbrette, D.L. (2003) Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am. J. Cardiol. 91, 39D-44D
5. Locati, E.H., Zareba, W., Moss, A.J., Schwartz, P.J., Vincent, G.M., Lehmann, M.H., Towbin, J.A., Priori, S.G., Napolitano, C., Robinson, J.L. et al. (1998) Age-and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation 97, 2237-2244
6. Dagres, N., Clague, J.R., Breithardt, G. and Borggrefe, M. (2003) Significant gender-related differences in radiofrequency catheter ablation therapy. J. Am. Coll. Cardiol. 42, 1103-1107
7. Langberg, J.J., Calkins, H., Kim, Y.N., Sousa, J., El-Atassi, R., Leon, A., Borganelli, M., Kalbfleisch, S.J. and Morady, F. (1992) Recurrence of conduction in accessory atrioventricular connections after initially successful radiofrequency catheter ablation. J. Am. Coll. Cardiol. 19, 1588-1592
8. Calkins, H., Yong, P., Miller, J.M., Olshansky, B., Carlson, M., Saul, J.P., Huang, S.K., Liem, L.B., Klein, L.S., Moser, S.A. et al. (1999) Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation 99, 262-270
9. Chugh, S.S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E.J., Gillum, R.F., Kim, Y.H., McAnulty, J.H., Zheng, Z.J. et al. (2014) Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 129, 837-847
10. Go, A.S., Hylek, E.M., Phillips, K.A., Chang, Y., Henault, L.E., Selby, J.V. and Singer, D. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285, 2370-2375
11. Colilla, S., Crow, A., Petkun, W., Singer, D.E., Simon, T. and Liu, X. (2013) Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am. J. Cardiol. 112, 1142-1147
12. Braunwald, E. and Bonow, R.O. (2012) Braunwald's Heart Disease a Textbook of Cardiovascular Medicine, Elsevier Saunders, Philadelphia, http://proxy.library.emory.edu/login?url=http://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20090597346
13. Feinberg, W.M., Blackshear, J.L., Laupacis, A., Kronmal, R. and Hart, R.G. (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Inter. Med. 155, 469-473
14. Zoni-Berisso, M., Lercari, F., Carazza, T. and Domenicucci, S. (2014) Epidemiology of atrial fibrillation: European perspective. Clin. Epidemiol. 6, 213-220
15. Benjamin, E.J., Wolf, P.A., D'Agostino, R.B., Silbershatz, H., Kannel, W.B. and Levy, D. (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98, 946-952
16. Andersson, T., Magnuson, A., Bryngelsson, I.L., Frobert, O., Henriksson, K.M., Edvardsson, N. et al. (2013) All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur. Heart J. 34, 1061-1067
17. Friberg, L., Benson, L., Rosenqvist, M. and Lip, G.Y. (2012) Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study. BMJ 344, e3522
18. Dagres, N., Nieuwlaat, R., Vardas, P.E., Andresen, D., Levy, S., Cobbe, S., Kremastinos, D.T., Breithardt, G., Cokkinos, D.V. and Crijns, H.J (2007) Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation. J. Am. Coll. Cardiol. 49, 572-577
19. Fang, M.C., Singer, D.E., Chang, Y., Hylek, E.M., Henault, L.E., Jensvold, N.G. and Go, A.S. (2005) Gender differences in the risk of ischaemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation 112, 1687-1691
20. Humphries, K.H., Kerr, C.R., Connolly, S.J., Klein, G., Boone, J.A., Green, M., Sheldon, R., Talajic, M., Dorian, P. and Newman, D. (2001) New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation 103, 2365-2370
21. Lane, D.A. and Lip, G.Y. (2009) Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients. Thromb. Haemost. 101, 802-805
22. Rienstra, M., Van Veldhuisen, D.J., Hagens, V.E., Ranchor, A.V., Veeger, N.J., Crijns, H.J. and Van Gelder, I.C. (2005) Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J. Am. Coll. Cardiol. 46, 1298-1306
23. Forleo, G.B., Tondo, C., De Luca, L., Dello Russo, A., Casella, M., De Sanctis, V., Clementi, F., Fagundes, R.L., Leo, R., Romeo, F. and Mantica, M. (2007) Gender-related differences in catheter ablation of atrial fibrillation. Europace 9, 613-620
24. Ghanbari, H., Dalloul, G., Hasan, R., Daccarett, M., Saba, S., David, S. and Machado, C. (2009) Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch. Intern. Med. 169, 1500-1506
25. Santangeli, P., Pelargonio, G., Dello Russo, A., Casella, M., Bisceglia, C., Bartoletti, S., Santarelli, P., Di Biase, L. and Natale, A. (2010) Gender differences in clinical outcome and primary prevention defibrillator benefit in patients with severe left ventricular dysfunction: a systematic review and meta-analysis. Heart Rhythm. 7, 876-882
26. Zeitler, E.P., Hellkamp, A.S., Fonarow, G.C., Hammill, S.C., Curtis, L.H., Hernandez, A.F., Al-Khalidi, H.R., Curtis, J.P., Heidenreich, P.A., Anstrom, K.J. et al. (2015) Primary prevention implantable cardioverter-defibrillators and survival in older women. JACC Heart Fail. 3, 159-167
27. Russo, A.M., Stainback, R.F., Bailey, S.R., Epstein, A.E., Heidenreich, P.A., Jessup, M., Kapa, S., Kremers, M.S., Lindsay, B.D. and Stevenson, L.W. (2013) ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Heart Rhythm 10, e11-e58
28. Curtis, L.H., Al-Khatib, S.M., Shea, A.M., Hammill, B.G., Hernandez, A.F. and Schulman, K.A. (2007) Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 298, 1517-1524
29. Hernandez, A.F., Fonarow, G.C., Liang, L., Al-Khatib, S.M., Curtis, L.H., LaBresh, K.A., Yancy, C.W., Albert, N.M. and Peterson, E.D. (2007) Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 298, 1525-1532
30. Hunter, S. and Robson, S.C. (1992) Adaptation of the maternal heart in pregnancy. Br. Heart J. 68, 540-543
31. Savu, O., Jurcut, R., Giusca, S., van Mieghem, T., Gussi, I., Popescu, B.A., Ginghina, C., Rademakers, F., Deprest, J. and Voigt, J.U. (2012) Morphological and functional adaptation of the maternal heart during pregnancy. Circ. Cardiovasc. Imag. 5, 289-297
32. Tanis, W., Stella, P.R., Kirkels, J.H., Pijlman, A.H., Peters, R.H. and de Man, F.H. (2008) Spontaneous coronary artery dissection: current insights and therapy. Neth. Heart J. 16, 344-349
33. Shotan, A., Ostrzega, E., Mehra, A., Johnson, J.V. and Elkayam, U. (1997) Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am. J. Cardiol. 79, 1061-1064
34. Tawam, M., Levine, J., Mendelson, M., Goldberger, J., Dyer, A. and Kadish, A. (1993) Effect of pregnancy on paroxysmal supraventricular tachycardia. Am. J. Cardiol. 72, 838-840
35. Li, J.M., Nguyen, C., Joglar, J.A., Hamdan, M.H. and Page, R.L. (2008) Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Clin. Cardiol. 31, 538-541
36. Robins, K. and Lyons, G. (2004) Supraventricular tachycardia in pregnancy. Br. J. Anaesth. 92, 140-143
37. Soliman, E.Z., Elsalam, M.A. and Li, Y. (2010) The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording. Europace 12, 261-265
38. Tateno, S., Niwa, K., Nakazawa, M., Akagi, T., Shinohara, T. and Yasuda, T. (2003) Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy: multicenter study. Circ. J. 67, 992-997
39. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S. et al. (2013) Heart disease and stroke statistics -2013 update: a report from the American Heart Association. Circulation 127, e6-e245
40. Levy, D., Kenchaiah, S., Larson, M.G., Benjamin, E.J., Kupka, M.J., Ho, K.K., Murabito, J.M. and Vasan, R.S. (2002) Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397-1402
41. Bursi, F., Weston, S.A., Redfield, M.M., Jacobsen, S.J., Pakhomov, S., Nkomo, V.T., Meverden, R.A. and Roger, V.L. (2006) Systolic and diastolic heart failure in the community. JAMA 296, 2209-2216
42. Lewis, E.F., Lamas, G.A., O'Meara, E., Granger, C.B., Dunlap, M.E., McKelvie, R.S., Probstfield, J.L., Young, J.B., Michelson, E.L., Halling, K. et al. (2007) Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur. J. Heart Fail. 9, 83-91
43. Lee, D.S., Gona, P., Vasan, R.S., Larson, M.G., Benjamin, E.J., Wang, T.J., Tu, J.V. and Levy, D. (2009) Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 119, 3070-3077
44. Masoudi, F.A., Havranek, E.P., Smith, G., Fish, R.H., Steiner, J.F., Ordin, D.L. and Krumholz, H.M. (2003) Gender, age, and heart failure with preserved left ventricular systolic function. J. Am. Coll. Cardiol. 41, 217-223
45. Ogden, C., Kit, B.K. and Flegal, K.M. (2013), Prevalence of obesity among adults: United States, 2011-2012. NCHS Data Brief [Internet]. 06/03/2014. http://www.cdc.gov/nchs/data/databriefs/db131.pdf
46. National Center for Health Statistics (US) (2014) Health, U.S. 2013: With Special Feature on Prescription Drugs, U.S. Government Printing Office, Hyattsville, MD
47. Redfield, M.M., Jacobsen, S.J., Borlaug, B.A., Rodeheffer, R.J. and Kass, D.A. (2005) Age-and gender-related ventricular-vascular stiffening: a community-based study. Circulation 112, 2254-2262
48. Pedrotty, D.M. and Jessup, M. (2015) "Frailty, thy name is woman": syndrome of women with heart failure with preserved ejection fraction. Circ. Cardiovasc. Qual. Outcomes 8 (2 Suppl 1), S48-S51
49. Regitz-Zagrosek, V., Brokat, S. and Tschope, C. (2007) Role of gender in heart failure with normal left ventricular ejection fraction. Prog. Cardiovasc. Dis. 49, 241-251
50. Zhao, Z., Wang, H., Jessup, J.A., Lindsey, S.H., Chappell, M.C. and Groban, L. (2014) Role of estrogen in diastolic dysfunction. Am. J. Physiol. Heart Circ. Physiol. 306, H628-H640
51. Borlaug, B.A. and Redfield, M.M. (2011) Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation 123, 2006-2013, discussion 14
52. Chan, M.M. and Lam, C.S. (2013) How do patients with heart failure with preserved ejection fraction die? Eur. J. Heart Fail. 15, 604-613
53. Lam, C.S., Carson, P.E., Anand, I.S., Rector, T.S., Kuskowski, M., Komajda, M., McKelvie, R.S., McMurray, J.J., Zile, M.R., Massie, B.M. and Kitzman, D.W. (2012) Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ. Heart Fail. 5, 571-578
54. Jones, R.C., Francis, G.S. and Lauer, M.S. (2004) Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J. Am. Coll. Cardiol. 44, 1025-1029
55. Fairweather, D., Cooper, Jr, L.T. and Blauwet, L.A. (2013) Sex and gender differences in myocarditis and dilated cardiomyopathy. Curr. Probl. Cardiol. 38, 7-46
56. Frazier, C.G., Alexander, K.P., Newby, L.K., Anderson, S., Iverson, E., Packer, M., Cohn, J., Goldstein, S. and Douglas, P.S. (2007) Associations of gender and etiology with outcomes in heart failure with systolic dysfunction: a pooled analysis of 5 randomized control trials. J. Am. Coll. Cardiol. 49, 1450-1458
57. Adams, Jr, K.F., Dunlap, S.H., Sueta, C.A., Clarke, S.W., Patterson, J.H., Blauwet, M.B., Jensen, L.R., Tomasko, L. and Koch, G. (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J. Am. Coll. Cardiol. 28, 1781-1788
58. Shekelle, P.G., Rich, M.W., Morton, S.C., Atkinson, C.S., Tu, W., Maglione, M., Rhodes, S., Barrett, M., Fonarow, G.C., Greenberg, B. et al. (2003) Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J. Am. Coll. Cardiol. 41, 1529-1538
59. Taylor, A.L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, Jr, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M. and Cohn, J.N. (2004) Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N. Engl. J. Med. 351, 2049-2057
60. Rathore, S.S., Wang, Y. and Krumholz, H.M. (2002) Sex-based differences in the effect of digoxin for the treatment of heart failure. N. Engl. J. Med. 347, 1403-1411
61. Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, Jr, D.E., Drazner, M.H., Fonarow, G.C., Geraci, S.A., Horwich, T., Januzzi, J.L. et al. (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 62, e147-e239
62. Moss, A.J., Hall, W.J., Cannom, D.S., Klein, H., Brown, M.W., Daubert, J.P., Estes, N.A., III, Foster, E., Greenberg, H., Higgins, S.L. et al. (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361, 1329-1338
63. Tang, A.S., Wells, G.A., Talajic, M., Arnold, M.O., Sheldon, R., Connolly, S., Hohnloser, S.H., Nichol, G., Birnie, D.H., Sapp, J.L. et al. (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N. Engl. J. Med. 363, 2385-2395
64. Cheng, Y.J., Zhang, J., Li, W.J., Lin, X.X., Zeng, W.T., Tang, K., Tang, A.L., He, J.G., Xu, Q., Mei, M.Y. et al. (2014) More favorable response to cardiac resynchronization therapy in women than in men. Circ. Arrhythm. Electrophysiol. 7, 807-815
65. Dickstein, K., Bogale, N., Priori, S., Auricchio, A., Cleland, J.G., Gitt, A., Limbourg, T., Linde, C., van Veldhuisen, D.J. and Brugada, J. (2009) The European cardiac resynchronization therapy survey. Eur. Heart J. 30, 2450-2460
66. Alaeddini, J., Wood, M.A., Amin, M.S. and Ellenbogen, K.A. (2008) Gender disparity in the use of cardiac resynchronization therapy in the United States. Pacing Clin. Electrophysiol. 31, 468-472
67. Bogaev, R.C., Pamboukian, S.V., Moore, S.A., Chen, L., John, R., Boyle, A.J., Sundareswaran, K.S., Farrar, D.J. and Frazier, O.H. (2011) Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation. J. Heart Lung Transplant. 30, 515-522
68. Weymann, A., Patil, N.P., Sabashnikov, A., Mohite, P.N., Garcia Saez, D., Amrani, M., Bahrami, T., De Robertis, F., Wahlers, T., Banner, N.R. et al. (2015) Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis. Artif. Organs 39, 212-219
69. Hsich, E.M., Naftel, D.C., Myers, S.L., Gorodeski, E.Z., Grady, K.L., Schmuhl, D., Ulisney, K.L. and Young, J.B. (2012) Should women receive left ventricular assist device support?: findings from INTERMACS. Circ. Heart Fail. 5, 234-240
70. Lampropulos, J.F., Kim, N., Wang, Y., Desai, M.M., Barreto-Filho, J.A., Dodson, J.A., Dries, D.L., Mangi, A.A. and Krumholz, H.M. (2014) Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011. Open Heart 1, e000109
71. Eifert, S., Kofler, S., Nickel, T., Horster, S., Bigdeli, A.K., Beiras-Fernandez, A., Meiser, B. and Kaczmarek, I. (2012) Gender-based analysis of outcome after heart transplantation. Exp. Clin. Transplant. 10, 368-374
72. Kaczmarek, I., Meiser, B., Beiras-Fernandez, A., Guethoff, S., Uberfuhr, P., Angele, M., Seeland, U., Hagl, C., Reichart, B. and Eifert, S. (2013) Gender does matter: gender-specific outcome analysis of 67,855 heart transplants. Thorac. Cardiovasc. Surg. 61, 29-36
73. Aaronson, K.D., Schwartz, J.S., Goin, J.E. and Mancini, D.M. (1995) Sex differences in patient acceptance of cardiac transplant candidacy. Circulation 91, 2753-2761
74. Regitz-Zagrosek, V., Petrov, G., Lehmkuhl, E., Smits, J.M., Babitsch, B., Brunhuber, C., Jurmann, B., Stein, J, Schubert, C., Merz, N.B. et al. (2010) Heart transplantation in women with dilated cardiomyopathy. Transplantation 89, 236-244
75. Cook, J.L., Grady, K.L., Colvin, M., Joseph, S.M., Brisco, M.A. and Walsh, M.N. (2015) Sex differences in the care of patients with advanced heart failure. Circ. Cardiovasc. Qual. Outcomes 8, (2 Suppl 1), S56-S59
76. Kolte, D., Khera, S., Aronow, W.S., Palaniswamy, C., Mujib, M., Ahn, C., Jain, D., Gass, A., Ahmed, A., Panza, J.A. and Fonarow, G.C. (2014) Temporal trends in incidence and outcomes of peripartum cardiomyopathy in the United States: a nationwide population-based study. J. Am. Heart Assoc. 3, e001056
77. Givertz, M.M. (2013) Cardiology patient page: peripartum cardiomyopathy. Circulation 127, e622-e626
78. Sliwa, K., Hilfiker-Kleiner, D., Petrie, M.C., Mebazaa, A., Pieske, B., Buchmann, E., Regitz-Zagrosek, V., Schaufelberger, M., Tavazzi, L., van Veldhuisen, D.J. et al. (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur. J. Heart Fail. 12, 767-778
79. Pearson, G.D., Veille, J.C., Rahimtoola, S., Hsia, J., Oakley, C.M., Hosenpud, J.D., Ansari, A. and Baughman, K.L. (2000) Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283, 1183-1188
80. Ramaraj, R. (2007) Stress cardiomyopathy: aetiology and management. Postgrad. Med. J. 83, 543-546
81. Sharkey, S.W., Windenburg, D.C., Lesser, J.R., Maron, M.S., Hauser, R.G., Lesser, J.N., Haas, T.S., Hodges, J.S. and Maron, B.J. (2010) Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J. Am. Coll. Cardiol. 55, 333-341
82. Prasad, A., Lerman, A. and Rihal, C.S. (2008) Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am. Heart J. 155, 408-817
83. Octavia, Y., Tocchetti, C.G., Gabrielson, K.L., Janssens, S., Crijns, H.J. and Moens, A.L. (2012) Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J. Mol. Cell. Cardiol. 52, 1213-1225
84. Lipshultz, S.E., Lipsitz, S.R., Mone, S.M., Goorin, A.M., Sallan, S.E., Sanders, S.P., Orav, E.J., Gelber, R.D. and Colan, S.D. (1995) Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N. Engl. J. Med. 332, 1738-1743
85. Shaw, L.J., Bugiardini, R. and Merz, C.N. (2009) Women and ischaemic heart disease: evolving knowledge. J. Am. Coll. Cardiol. 54, 1561-1575
86. Anand, S.S., Islam, S., Rosengren, A., Franzosi, M.G., Steyn, K., Yusufali, A.H., Keltai, M., Diaz, R., Rangarajan, S. and Yusuf, S. (2008) Risk factors for myocardial infarction in women and men: insights from the interheart study. Eur. Heart J. 29, 932-940
87. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Blaha, M.J., Dai, S., Ford, E.S., Fox, C.S., Franco, S. et al. (2014) Heart disease and stroke statistics -2014 update: a report from the American Heart Association. Circulation 129, e28-e292
88. Sattelmair, J., Pertman, J., Ding, E.L., Kohl, 3rd, H.W., Haskell, W. and Lee, I.M. (2011) Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation 124, 789-795
89. Peters, S.A., Huxley, R.R. and Woodward, M. (2014) Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 57, 1542-1551
90. Woodard, G.A., Brooks, M.M., Barinas-Mitchell, E., Mackey, R.H., Matthews, K.A. and Sutton-Tyrrell, K. (2011) Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 18, 376-384
91. Nordestgaard, B.G., Benn, M., Schnohr, P. and Tybjaerg-Hansen, A. (2007) Nonfasting triglycerides and risk of myocardial infarction, ischaemic heart disease, and death in men and women. JAMA 298, 299-308
92. American Lung Association (2011), Trends in Tobacco Use [Webpage], [05/22/14], http://www.lung.org/finding-cures/our-research/trend-reports/Tobacco-Trend-Report.pdf
93. Kawachi, I., Colditz, G.A., Stampfer, M.J., Willett, W.C., Manson, J.E., Rosner, B., Speizer, F.E. and Hennekens, C.H. (1994) Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch. Intern. Med. 154, 169-175
94. Flint, A.J., Hu, F.B., Glynn, R.J., Caspard, H., Manson, J.E., Willett, W.C. and Rimm, E.B. (2010) Excess weight and the risk of incident coronary heart disease among men and women. Obesity 18, 377-383
95. Dubey, R.K., Imthurn, B., Barton, M. and Jackson, E.K. (2005) Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66, 295-306
96. Nathan, L. and Chaudhuri, G. (1997) Estrogens and atherosclerosis. Annu. Rev. Pharmacol. Toxicol. 37, 477-515
97. Bittner, V. (2009) Menopause, age, and cardiovascular risk: a complex relationship. J. Am. Coll. Cardiol. 54, 2374-2375
98. Fraser, A., Nelson, S.M., Macdonald-Wallis, C., Cherry, L., Butler, E., Sattar, N. and Lawlor, D.A. (2012) Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation 125, 1367-1380
99. Intapad, S. and Alexander, B.T. (2013) Future cardiovascular risk: Interpreting the importance of increased blood pressure during pregnancy. Circulation 127, 668-669
100. Shoenfeld, Y., Gerli, R., Doria, A., Matsuura, E., Cerinic, M.M., Ronda, N., Jara, L.J., Abu-Shakra, M., Meroni, P.L. and Sherer, Y. (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112, 3337-3347
101. Finn, A.V., Nakano, M., Narula, J., Kolodgie, F.D. and Virmani, R. (2010) Concept of vulnerable/unstable plaque. Arterioscle. Thromb. Vasc. Biol. 30, 1282-1292
102. Arbustini, E., Dal Bello, B., Morbini, P., Burke, A.P., Bocciarelli, M., Specchia, G. and Virmani, R. (1999) Plaque erosion is a major substrate for coronary thrombosis in acute myocardial infarction. Heart 82, 269-272
103. Saw, J., Ricci, D., Starovoytov, A., Fox, R. and Buller, C.E. (2013) Spontaneous coronary artery dissection: prevalence of predisposing conditions including fibromuscular dysplasia in a tertiary center cohort. JACC Cardiovasc. Interv. 6, 44-52
104. Biswas, M., Sethi, A. and Voyce, S.J. (2012) Spontaneous coronary artery dissection: case report and review of literature. Heart Views 13, 149-154
105. James, A.H., Jamison, M.G., Biswas, M.S., Brancazio, L.R., Swamy, G.K. and Myers, E.R. (2006) Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 113, 1564-1571
106. Elkayam, U., Jalnapurkar, S., Barakkat, M.N., Khatri, N., Kealey, A.J., Mehra, A. and Roth, A. (2014) Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation 129, 1695-1702
107. Yahagi, K., Davis, H.R., Arbustini, E. and Virmani, R. (2015) Sex differences in coronary artery disease: pathological observations. Atherosclerosis 239, 260-267
108. Reis, S.E., Holubkov, R., Conrad Smith, A.J., Kelsey, S.F., Sharaf, B.L., Reichek, N., Rogers, W.J., Merz, C.N., Sopko, G. and Pepine, C.J. (2001) Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am. Heart J. 141, 735-741
109. Sullivan, A.K., Holdright, D.R., Wright, C.A., Sparrow, J.L., Cunningham, D. and Fox, K.M. (1994) Chest pain in women: clinical, investigative, and prognostic features. BMJ 308, 883-886
110. Bairey Merz, C.N. and Pepine, C.J. (2011) Syndrome X and microvascular coronary dysfunction. Circulation 124, 1477-1480
111. Camici, P.G. and Crea, F. (2007) Coronary microvascular dysfunction. N. Engl. J. Med. 356, 830-840
112. Bairey Merz, C.N., Shaw, L.J., Reis, S.E., Bittner, V., Kelsey, S.F., Olson, M., Johnson, B.D., Pepine, C.J., Mankad, S. and Sharaf, B.L. (2006) Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J. Am. Coll. Cardiol. 47 (3 Suppl), S21-S29
113. Titterington, J.S., Hung, O.Y. and Wenger, N.K. (2015) Microvascular angina: an update on diagnosis and treatment. Future Cardiol. 11, 229-242
114. Shaw, L.J., Min, J.K., Narula, J., Lin, F., Bairey-Merz, C.N., Callister, T.Q. and Berman, D.S. (2010) Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis. Circ. Cardiovasc. Imag. 3, 473-481
115. Gulati, M., Cooper-DeHoff, R.M., McClure, C., Johnson, B.D., Shaw, L.J., Handberg, E.M., Zineh, I., Kelsey, S.F., Arnsdorf, M.F., Black, H.R. et al. (2009) Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch. Intern. Med. 169, 843-850
116. Otten, A.M., Maas, A.H., Ottervanger, J.P., Kloosterman, A., van't Hof, A.W., Dambrink, J.H., Gosselink, A.T., Hoorntje, J.C., Suryapranata, H. and de Boer, M.J. (2013) Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. Eur. Heart J. Acute Cardiovasc. Care 2, 334-341
117. Canto, J.G., Rogers, W.J., Goldberg, R.J., Peterson, E.D., Wenger, N.K., Vaccarino, V., Kiefe, C.I., Frederick, P.D., Sopko, G. and Zheng, Z.J. (2012) Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA 307, 813-822
118. Blomkalns, A.L., Chen, A.Y., Hochman, J.S., Peterson, E.D., Trynosky, K., Diercks, D.B., Brogan, G.X., Jr, Boden, W.E., Roe, M.T., Ohman, E.M. et al. (2005) Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (can rapid risk stratification of unstable angina patients suppress adverse outcomes with early implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J. Am. Coll. Cardiol. 45, 832-837
119. Gupta, A., Wang, Y., Spertus, J.A., Geda, M., Lorenze, N., Nkonde-Price, C., D'Onofrio, G., Lichtman, J.H. and Krumholz, H.M. (2014) Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J. Am. Coll. Cardiol. 64, 337-345
120. Dreyer, R.P., Wang, Y., Strait, K.M., Lorenze, N.P., D'Onofrio, G., Bueno, H., Lichtman, J.H., Spertus, J.A. and Krumholz, H.M. (2015) Gender differences in the trajectory of recovery in health status among young patients with acute myocardial infarction: results from the variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study. Circulation 131, 1971-1980
121. D'Onofrio, G., Safdar, B., Lichtman, J.H., Strait, K.M., Dreyer, R.P., Geda, M., Spertus, J.A. and Krumholz, H.M. (2015) Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation 131, 1324-1332
122. Caulin-Glaser, T., Blum, M., Schmeizl, R., Prigerson, H.G., Zaret, B. and Mazure, C.M. (2001) Gender differences in referral to cardiac rehabilitation programs after revascularization. J. Cardiopulm. Rehabil. 21, 24-30
123. Samayoa, L., Grace, S.L., Gravely, S., Scott, L.B., Marzolini, S. and Colella, T.J. (2014) Sex differences in cardiac rehabilitation enrollment: a meta-analysis. Can. J. Cardiol. 30, 793-800
124. Avierinos, J.F., Inamo, J., Grigioni, F., Gersh, B., Shub, C. and Enriquez-Sarano, M. (2008) Sex differences in morphology and outcomes of mitral valve prolapse. Ann. Intern. Med. 149, 787-795
125. Osnabrugge, R.L., Mylotte, D., Head, S.J., Van Mieghem, N.M., Nkomo, V.T., LeReun, C.M., Bogers, A.J., Piazza, N. and Kappetein, A.P. (2013) Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J. Am. Coll. Cardiol. 62, 1002-1012
126. O'Connor, S.A., Morice, M.C., Gilard, M., Leon, M.B., Webb, J.G., Dvir, D., Rodes-Cabau, J., Tamburino, C., Capodanno, D., D'Ascenzo, F. et al. (2015) Revisiting sex equality with transcatheter aortic valve replacement outcomes: a collaborative, patient-level meta-analysis of 11,310 patients. J. Am. Coll. Cardiol. 66, 221-228
127. Zhao, Z.G., Liao, Y.B., Peng, Y., Chai, H., Liu, W., Li, Q., Ren, X., Wang, X.Q., Luo, X.L., Zhang, C. et al. (2013) Sex-related differences in outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis. Circ. Cardiovasc. Interv. 6, 543-551
128. Stangl, V., Baldenhofer, G., Knebel, F., Zhang, K., Sanad, W., Spethmann, S., Grubitzsch, H., Sander, M., Wernecke, K.D., Baumann, G. et al. (2012) Impact of gender on three-month outcome and left ventricular remodeling after transfemoral transcatheter aortic valve implantation. Am. J. Cardiol. 110, 884-890
129. Wenger, N.K. (2012) Cardiovascular disease: the female heart is vulnerable: a call to action from the 10Q report. Clin. Cardiol. 35, 134-135